The future of INSTIs in HIV management looks promising, with ongoing research focused on improving their efficacy, reducing side effects, and developing long-acting formulations. Newer INSTIs with enhanced resistance profiles are also being explored. As our understanding of HIV and its interaction with the human immune system evolves, INSTIs will continue to play a pivotal role in the development of innovative treatment strategies.
